Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Component of oligomeric Golgi complex subunit 2 (COG2) is a protein-coding gene that encodes a subunit of the conserved oligomeric Golgi (COG) complex, which is essential for maintaining the normal structure and activity of the Golgi apparatus. The COG complex, including COG2, facilitates retrograde vesicular trafficking within the Golgi and is required for proper glycoprotein modification and enzyme localization. Mutations in COG2 can cause congenital disorders of glycosylation, leading to defects in protein glycosylation and associated clinical syndromes. COG2 operates by mediating the initial physical contact between transport vesicles and their membrane targets, akin to other Golgi tethering complexes. There are no approved or known drugs targeting COG2, and it is not considered a classical therapeutic target, receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Component of oligomeric Golgi complex subunit 2 (COG2).